Cargando…

Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies

BACKGROUND: Adenoviruses are common pathogens infecting animals and humans. They are classified based on serology, or genome sequence information. These methods have limitations due to lengthy procedures or lack of infectivity data. Adenoviruses are easy to produce and amenable to genetic and bioche...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacesa, Martin, Hendrickx, Rodinde, Bieri, Manuela, Flatt, Justin W., Greber, Urs F., Hemmi, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563037/
https://www.ncbi.nlm.nih.gov/pubmed/28821267
http://dx.doi.org/10.1186/s12985-017-0822-5
_version_ 1783258061971914752
author Pacesa, Martin
Hendrickx, Rodinde
Bieri, Manuela
Flatt, Justin W.
Greber, Urs F.
Hemmi, Silvio
author_facet Pacesa, Martin
Hendrickx, Rodinde
Bieri, Manuela
Flatt, Justin W.
Greber, Urs F.
Hemmi, Silvio
author_sort Pacesa, Martin
collection PubMed
description BACKGROUND: Adenoviruses are common pathogens infecting animals and humans. They are classified based on serology, or genome sequence information. These methods have limitations due to lengthy procedures or lack of infectivity data. Adenoviruses are easy to produce and amenable to genetic and biochemical modifications, which makes them a powerful tool for biological studies, and clinical gene-delivery and vaccine applications. Antibodies directed against adenoviral proteins are important diagnostic tools for virus identification in vivo and in vitro, and are used to elucidate infection mechanisms, often in combination with genomic sequencing and type specific information from hyper-variable regions of structural proteins. RESULTS: Here we describe a novel and readily useable method for cloning, expressing and purifying small fragments of hyper-variable regions 1-6 of the adenoviral hexon protein. We used these polypeptides as antigens for generating polyclonal rabbit antibodies against human adenovirus 3 (HAdV-B3), mouse adenovirus 1 (MAdV-1) and MAdV-2 hexon. In Western immunoblots with lysates from cells infected from thirteen human and three mouse viruses, these antibodies bound to homologous full-length hexon protein and revealed variable levels of cross-reactivity to heterologous hexons. Results from immuno-fluorescence and electron microscopy studies indicated that HAdV-B3 and MAdV-2 hexon antibodies recognized native forms of hexon. CONCLUSIONS: The procedure described here can in principle be applied to any adenovirus for which genome sequence information is available. It provides a basis for generating novel type-specific tools in diagnostics and research, and extends beyond the commonly used anti-viral antibodies raised against purified viruses or subviral components. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12985-017-0822-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5563037
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55630372017-08-21 Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies Pacesa, Martin Hendrickx, Rodinde Bieri, Manuela Flatt, Justin W. Greber, Urs F. Hemmi, Silvio Virol J Research BACKGROUND: Adenoviruses are common pathogens infecting animals and humans. They are classified based on serology, or genome sequence information. These methods have limitations due to lengthy procedures or lack of infectivity data. Adenoviruses are easy to produce and amenable to genetic and biochemical modifications, which makes them a powerful tool for biological studies, and clinical gene-delivery and vaccine applications. Antibodies directed against adenoviral proteins are important diagnostic tools for virus identification in vivo and in vitro, and are used to elucidate infection mechanisms, often in combination with genomic sequencing and type specific information from hyper-variable regions of structural proteins. RESULTS: Here we describe a novel and readily useable method for cloning, expressing and purifying small fragments of hyper-variable regions 1-6 of the adenoviral hexon protein. We used these polypeptides as antigens for generating polyclonal rabbit antibodies against human adenovirus 3 (HAdV-B3), mouse adenovirus 1 (MAdV-1) and MAdV-2 hexon. In Western immunoblots with lysates from cells infected from thirteen human and three mouse viruses, these antibodies bound to homologous full-length hexon protein and revealed variable levels of cross-reactivity to heterologous hexons. Results from immuno-fluorescence and electron microscopy studies indicated that HAdV-B3 and MAdV-2 hexon antibodies recognized native forms of hexon. CONCLUSIONS: The procedure described here can in principle be applied to any adenovirus for which genome sequence information is available. It provides a basis for generating novel type-specific tools in diagnostics and research, and extends beyond the commonly used anti-viral antibodies raised against purified viruses or subviral components. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12985-017-0822-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-18 /pmc/articles/PMC5563037/ /pubmed/28821267 http://dx.doi.org/10.1186/s12985-017-0822-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pacesa, Martin
Hendrickx, Rodinde
Bieri, Manuela
Flatt, Justin W.
Greber, Urs F.
Hemmi, Silvio
Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
title Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
title_full Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
title_fullStr Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
title_full_unstemmed Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
title_short Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
title_sort small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563037/
https://www.ncbi.nlm.nih.gov/pubmed/28821267
http://dx.doi.org/10.1186/s12985-017-0822-5
work_keys_str_mv AT pacesamartin smallsizerecombinantadenoviralhexonproteinfragmentsfortheproductionofvirustypespecificantibodies
AT hendrickxrodinde smallsizerecombinantadenoviralhexonproteinfragmentsfortheproductionofvirustypespecificantibodies
AT bierimanuela smallsizerecombinantadenoviralhexonproteinfragmentsfortheproductionofvirustypespecificantibodies
AT flattjustinw smallsizerecombinantadenoviralhexonproteinfragmentsfortheproductionofvirustypespecificantibodies
AT greberursf smallsizerecombinantadenoviralhexonproteinfragmentsfortheproductionofvirustypespecificantibodies
AT hemmisilvio smallsizerecombinantadenoviralhexonproteinfragmentsfortheproductionofvirustypespecificantibodies